Clindamycin 2,4-Diphosphate (CAS 1309048-48-3)

Clindamycin 2,4-diphosphate is a derivative of clindamycin, which itself is a lincosamide antibiotic synthesized from lincomycin. This particular derivative is utilized primarily in biochemical research for its unique properties related to cellular uptake and interaction with bacterial proteins. Unlike its parent compound, this phosphate ester form may offer different solubility and stability characteristics that are beneficial for in vitro experiments. The action mechanism of clindamycin 2,4-diphosphate involves inhibition of protein synthesis in susceptible bacteria, similar to that of the parent compound. It binds to the 50S subunit of the bacterial ribosome, thereby blocking the peptidyl transferase center. This prevents the elongation of protein chains, leading to termination of protein synthesis. This ribosomal interaction is a focal point in studying the impacts of antibiotic interactions at a molecular level. In scientific research, clindamycin 2,4-diphosphate is particularly useful for studying the transport and cellular uptake mechanisms in bacterial cells, as the phosphate groups may influence its permeability and retention within different environments. Additionally, this compound is employed in the study of ribosome structure and function, providing insights into how modifications in antibiotic structure can affect their interaction with the ribosome and potentially enhance their specificity and efficacy.